Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.
In Jehovah's Witness patients, the use of red blood cells, platelets, and fresh frozen plasma is not optional. Various blood conservation techniques are available, but complex cardiac surgery remains a major challenge. The feasibility of fractions of "primary components" has not been fully considered in published case reports. For Jehovah's Witness patients who preoperatively give consent, factor IX concentrates may be acceptable for hemostatic therapy. We hereby describe a combination of "secondary components" to prevent excessive bleeding in a Jehovah's Witness patient undergoing complex replacement of the aortic arch.
Bolliger
Daniel
D
Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia, USA.
Sreeram
Gautam
G
Duncan
Alexander
A
Molinaro
Ross J
RJ
Szlam
Fania
F
Chen
Edward P
EP
Tanaka
Kenichi A
KA
D001013:Aorta, Thoracic / Q000601:surgery*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D005164:Factor IX / Q000627:therapeutic use*; D005260:Female; D006488:Hemostasis, Surgical; D006801:Humans; D033221:Jehovah's Witnesses; D008875:Middle Aged; D014656:Vascular Surgical Procedures
D005164:Factor IX